# Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma

> **NCT00004148** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 12 (actual)

## Conditions studied

- Melanoma (Skin)

## Interventions

- **BIOLOGICAL:** recombinant vaccinia-B7.1 vaccine

## Key facts

- **NCT ID:** NCT00004148
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2006-04
- **Final completion:** —
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004148, "Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00004148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*